Semler Scientific Inc. (SMLR)
undefined
undefined%
At close: undefined

Company Description

Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States.

The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups.

The company offers its products through salespersons and distributors.

Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.

Semler Scientific Inc.
Semler Scientific Inc. logo
Country United States
IPO Date Feb 21, 2014
Industry Medical - Devices
Sector Healthcare
Employees 92
CEO Dr. Douglas Murphy-Chutorian M.D.

Contact Details

Address:
2340-2348 Walsh Avenue
Santa Clara, California
United States
Website https://www.semlerscientific.com

Stock Details

Ticker Symbol SMLR
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001554859
CUSIP Number 81684M104
ISIN Number US81684M1045
Employer ID 26-1367393
SIC Code 3845

Key Executives

Name Position
Dr. Douglas Murphy-Chutorian M.D. Chief Executive Officer, President & Director
Jennifer Oliva Herrington Chief Operating Officer
Renae Cormier Chief Financial Officer, Principal Accounting Officer, Head of Corporation Communications & Bus. Strategy and Secretary
Shane Reid Chief Technology Officer
Cindy Guinasso Senior Vice President of Business Development
Dr. Herbert J. Semler Founder & Chairman Emeritus

Latest SEC Filings

Date Type Title
Dec 12, 2024 SC 13D/A [Amend] Filing
Dec 12, 2024 4 Filing
Dec 05, 2024 8-K Current Report
Nov 26, 2024 SC 13G Statement of acquisition of beneficial ownership b...
Nov 25, 2024 8-K Current Report
Nov 25, 2024 424B5 Filing
Nov 18, 2024 8-K Current Report
Nov 12, 2024 SC 13D/A [Amend] Filing
Nov 12, 2024 4 Filing
Nov 12, 2024 4 Filing